el-Zimaity H M, Jackson F W, Graham D Y
Baylor College of Medicine, VAMC, Houston, Texas, USA.
Am J Gastroenterol. 1997 Oct;92(10):1858-60.
Side effects of omeprazole therapy include reversible hypergastrinemia, entero chromaffin-like hyperplasia, and possibly acceleration of atrophic gastritis in the gastric corpus in patients with Helicobacter pylori infection. The objective of this report is to describe six cases of fundic gland polyps that developed while omeprazole was being used for Barrett's esophagus.
Three women and three men developed fundic gland polyps after 1-5 yr of omeprazole therapy, 20 mg/day. In the index case, fundal polyps developed after 2 yr of continuous omeprazole therapy. Omeprazole was stopped, but because of poor clinical efficacy with H2-blockers, it was reinstated.
After 4 yr of therapy, multiple large fundal polyps were present. Histology of all lesions revealed characteristic fundal gland polyps with multiple cystic dilations. None of the patients had H. pylori infection. Serum gastrin was normal in four and slightly increased in two.
These cases support the possible causal relation between the use of omeprazole and the development of fundic gland polyps in patients without H. pylori gastritis.
奥美拉唑治疗的副作用包括可逆性高胃泌素血症、肠嗜铬样细胞增生,对于幽门螺杆菌感染患者,还可能加速胃体萎缩性胃炎的进展。本报告的目的是描述6例在使用奥美拉唑治疗巴雷特食管时发生胃底腺息肉的病例。
3名女性和3名男性在接受奥美拉唑治疗(20毫克/天)1至5年后发生胃底腺息肉。在首例病例中,连续使用奥美拉唑2年后出现胃底息肉。停用奥美拉唑,但由于使用H2受体阻滞剂临床疗效不佳,又重新使用。
治疗4年后,出现多个大的胃底息肉。所有病变的组织学检查均显示为具有多个囊性扩张的典型胃底腺息肉。所有患者均无幽门螺杆菌感染。4例患者血清胃泌素正常,2例略有升高。
这些病例支持在无幽门螺杆菌胃炎的患者中,使用奥美拉唑与胃底腺息肉发生之间可能存在因果关系。